Anacetrapib in combination with a statin for patients with primary hypercholesterolaemia or mixed dyslipidaemia – adjunctive therapy
Anacetrapib is a new drug that may reduce the level of fats, like cholesterol, in your blood. High cholesterol can increase the risk of diseases such as heart attack and stroke, which are the main cause of death in the UK, accounting for over a quarter of all deaths each year. Anacetrapib is given as a tablet in combination with another drug (a statin), which is already used to lower ‘bad’ cholesterol. If anacetrapib can increase ‘good’ cholesterol, it may help reduce deaths and illness caused by heart disease and strokes.